La FDA, el regulador de los medicamentos en Estados unidos de Estados Unidos, ha aprobado, dentro de un proceso de revisi�n acelerada, el f�rmaco de Revolution Medicines para el...

Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…

The U.S. Food and Drug Administration on Wednesday approved Revolution Medicines’ targeted drug for adults with metastatic pancreatic cancer who have received prior treatment or…